证券研究报告 2024 年 08 月 28 日 湘财证券研究所 行业研究 钢铁行业周报 相关研究： | --- | --- | |-------------------------------------|------------| | | | | 1 《 . 淡季特征显现，钢厂盈利水平 | | | 新低》 2024.08.07 | | | 2. 《供给收缩，需求不振，钢价震 | | | 荡偏弱》 | 2024.08.13 | 行业评级：增持 近十二个月行业表现 -20% -15% -10% -5% 0% 5% 10% -25% -20% -15% -10% -5% 0% 5% 10% 钢铁(申万) 沪深300 | --- | --- | --- | --- | |----------|--------------------|----------|------------| | | | | | | | | | | | % | 1 个月 | 3 个月 | 12 个月 | | 相对收益 | -10 | -4 | -12 | | 绝对收益 | -17 | -6 | -22 | | | 注：相对收益与沪深 | | ...

Investment Rating - The report maintains an "Overweight" rating for the rare earth permanent magnet materials industry [1][2]. Core Insights - The rare earth permanent magnet industry experienced a decline of 3.15% last week, underperforming the benchmark by 2.6 percentage points. The industry valuation (TTM P/E) decreased by 2.01x to 33.15x, returning to a historical percentile of 27.6% [1]. - Domestic light rare earth ore prices remained stable, while heavy rare earth ore prices continued to rise. The prices of praseodymium-neodymium showed a steady increase, with the average price of praseodymium-neodymium oxide rising by 1.55% to 393,000 CNY/ton [1][2]. - The second batch of rare earth mining and smelting separation total control indicators for 2024 has been issued, indicating a significant contraction in rare earth supply growth [1][2]. Summary by Sections Market Trends - Last week, the rare earth permanent magnet industry continued its downward trend, with a weekly decline of 3.15% [1]. - The prices of mixed carbonate rare earth ore and various heavy rare earth ores remained stable, while the price of imported monazite ore increased by 1.69% to 362,000 CNY/ton [1]. Price Movements - The average price of praseodymium-neodymium oxide increased by 1.55% to 393,000 CNY/ton, while the average price of praseodymium-neodymium metal rose by 1.25% to 485,000 CNY/ton [1][2]. - The price of sintered neodymium-iron-boron continued to rise, with the average price of N35 grade increasing by 1.95% to 104.5 CNY/kg [1]. Supply and Demand Dynamics - The report highlights that the demand for rare earth materials is expected to increase due to seasonal factors and new orders from end-users, particularly in the automotive sector [2]. - The supply side remains robust, with July production of neodymium-iron-boron maintaining high growth, although the price increase potential for rare earth magnetic materials may be constrained by marginal supply-demand changes [2].

Investment Rating - The industry investment rating is "Overweight" [2][9][26] Core Viewpoints - The lithium battery materials industry experienced a decline of 3.74% last week, underperforming the benchmark (CSI 300) by 3.18 percentage points, with the valuation (TTM P/E) dropping to 18.85x, which is at a historical percentile of 2.8% [3][9] - The demand in the power market is limited, and the small power market remains in the off-season, while the recent growth in the energy storage market is concentrated among leading companies [9][26] - The industry is facing low profitability due to oversupply in the supply chain and pressure to reduce costs from downstream [9][26] Summary by Sections Market Conditions - Last week, the lithium battery materials industry saw a 3.74% decline, with a valuation drop to 18.85x [3] - The industry has a historical valuation percentile of 2.8% [3] Positive Material Trends - Lithium carbonate prices rebounded by 1.39% to 73,000 CNY/ton, while battery-grade lithium hydroxide prices decreased by 1.31% to 75,500 CNY/ton [3] - The price of lithium iron phosphate (LFP) decreased by 0.48% to 10,400 CNY/ton [3] Negative Material Trends - The price of ternary precursor materials remained stable, while ternary materials saw a slight decline [3] - The production of ternary materials was 14,635 tons, with a slight decrease of 0.14% week-on-week [3] Electrolyte Market - The average price of lithium hexafluorophosphate remained stable at 54,000 CNY/ton, while the production of electrolytes increased by 1.25% to 25,925 tons [4][5] Anode Materials - The average price of artificial graphite anode materials remained stable at 33,500 CNY/ton, with production decreasing by 0.72% to 37,860 tons [6] Separator Market - The price of dry separators remained stable at 0.43 CNY/sqm, with production increasing by 1.6% to 41,250 million sqm [7] Copper Foil Market - The average market price for lithium battery copper foil remained stable, with processing fees unchanged [8] Investment Recommendations - The report suggests that while there is support for long-term demand growth due to policies promoting new energy vehicles, the overall profitability outlook for the sector remains weak [9][26]

Investment Rating - The industry is rated as "Overweight" with a focus on three main investment themes [5]. Core Views - The report emphasizes the importance of innovation and heritage in the development of the traditional Chinese medicine (TCM) industry, highlighting the need for transformation and empowerment to drive high-quality growth [5]. - The report suggests that the TCM sector is experiencing a relative decline in performance compared to other pharmaceutical sub-sectors, but it has shown resilience with a smaller drop in value [2][10]. - The report indicates that OTC and branded TCM companies have performed better than innovative TCM drugs, continuing a positive trend from the first quarter [4]. Summary by Sections Market Performance - The TCM index decreased by 3.59% last week, while the overall pharmaceutical sector fell by 4.99%. Since the beginning of 2024, the TCM sector has dropped by 15.77%, which is less than the 25.02% decline in the broader pharmaceutical sector [2][10]. - Among the companies, Xiangxue Pharmaceutical, Lingrui Pharmaceutical, Yunnan Baiyao, and others showed strong performance, while companies like *ST Jiyuan and Hula娃 lagged behind [2]. Valuation Metrics - The TCM sector's PE ratio is 24.05X, down 0.85X from the previous week, with a PB ratio of 2.14X, down 0.07X. The PE is at the 19.7th percentile and the PB at the 2.8th percentile over the past decade [3]. Company Performance - As of August 28, 2024, 42 TCM companies have disclosed their semi-annual reports, with 30.95% showing revenue growth and 50% showing net profit growth. Companies with over 20% revenue growth account for 7.14%, while those with over 20% net profit growth account for 19.05% [4]. Investment Recommendations - The report identifies three main investment themes: 1. "Drug" innovation focusing on TCM innovative drugs, driven by policy and clinical demand [5]. 2. "Drug" rejuvenation focusing on branded TCM, leveraging competitive advantages and market innovations [8]. 3. State-owned enterprise reform, emphasizing quality improvement and efficiency in state-controlled enterprises [8].

证券研究报告 2024 年 08 月 28 日 湘财证券研究所 公司研究 浙江鼎力（603338）事件点评 收入保持快速增长，臂式产品占比持续提升 相关研究： 1.《20240322湘财证券-603338.SH 浙江鼎力：五期工厂陆续投产， 收购CMEC强化海外优势》 公司评级：增持（维持） 近十二个月公司表现 | --- | --- | |-------------|-------------| | | 沪深300 | | 60% | | | 40% | | | 20% | | | 0% | | | -20% | | | 23/08 23/10 | 24/06 24/08 | | % | 12 个月 | | 相对收益 | | | 绝对收益 | | 分析师：轩鹏程 证书编号：S0500521070003 Tel：(8621) 50295321 Email：xuanpc@xcsc.com 地址：上海市浦东新区银城路 88 号 中国人寿金融中心 10 楼 核心要点： ❑ 公司发布 2024 年半年报，收入保持快速增长 近日，公司发布 2024 年半年度报告。上半年公司实现营业收入约 38.6 亿元，同比增长 24 ...

证券研究报告 2024 年 08 月 28 日 湘财证券研究所 公司研究 安徽合力（600761）事件点评 相关研究： 1.《20240716湘财证券-安徽合力 600761.SH-国内叉车龙头，国际化 助力公司持续发展》 % 1 个月 3 个月 12 个月 相对收益 -6.5 -28.9 -6.9 绝对收益 -10.1 -38.5 -18.3 注：相对收益与沪深 300 相比 业绩保持快速增长，盈利能力持续提升 核心要点： ❑ 公司发布 2024 年半年报，业绩保持快速增长 近日，公司发布 2024 年半年度报告。2024 年上半年，公司实现营业收 入约 90.1 亿元，同比增长 3.3%；归母净利润约 8.0 亿元，同比增长 22.0%； 扣非后归母净利润约 7.2 亿元，同比增长 26.8%；经营活动现金净流量约 2.6 亿元，同比减少 45.4%；基本每股收益约 1.04 元，同比增长 16.8%；加权平 均 ROE 约 9.5%，同比增加 0.3 个百分点。2024 年第二季度，公司营业收入 约 47.0 亿元，同比增长 4.1%；归母净利润 4.1 亿元，同比增长 4.5%；扣非 后归母净利润约 ...

证券研究报告 2024 年 08 月 27 日 湘财证券研究所 行业研究 医疗服务行业周报 中报密集披露，ADC CDMO 业绩表现靓丽 --医疗服务行业周报 8.19-8.23 | --- | --- | --- | --- | |------------------|--------------------------------------------|------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 相关研究： | | | 核心要点： | | 1. | | | 上周医药生物下跌 4.99%，位列申万一级行业第 29 位 | | | | 2024.08.12 | 上周医药生物报收 6653.23 点，下跌 4.99%， ...

证券研究报告 2024 年 08 月 28 日 湘财证券研究所 电厂日耗见顶，煤价震荡下行 相关研究： 行业评级：增持 近十二个月行业表现 -10% 0% 10% 20% 30% 40% 煤炭(申万) 沪深300 -24% -18% -12% -6% 0% 6% 12% 分析师：王逸奇 证书编号：S0500524080002 Tel：(8621) 50293519 Email：wyq06893@xcsc.com 地址：上海市浦东新区银城路88号 中国人寿金融中心10楼湘财证券研 究所 核心要点： ❑ 市场回顾：煤炭板块下跌 3.51%，估值周环比下滑 上周（8.19-8.25）煤炭板块（801950.SI）下跌 3.51%，同期沪深 300 下跌 0.55%，行业跑输基准指数（沪深 300）2.96 个百分点。煤炭行业板块 PE 估值为 11 倍，处于近十年来 57.3%分位点；板块 PB 估值为 1.26 倍，处 于近十年来 33.86%分位点，估值周环比下滑。 ❑ 电厂日耗见顶，煤价震荡下行 国内动力煤价格下跌，国外动力煤价格稳中有涨。国内方面：截至 8 月 25日，CCTD 秦皇岛Q5500动力煤市场价 ...

证券研究报告 2024 年 08 月 27 日 湘财证券研究所 行业研究 疫苗行业周报 1. 《多款疫苗获新进展，三大因 素驱动行业长期向好》 20240804 2. 《板块回调，近期建议关注中 报业绩》 20240814 % 1 个月 3 个月 12 个月 相对收益 -5 -13 -30 绝对收益 -7 -20 -42 进入业绩密集披露期，短期关注中报业绩 核心要点： 相关研究： ❑ 市场表现：上周疫苗下跌 6.32%，医药板块全面回调 上周（2024.08.19-2024.08.23）医药生物报收 6321.08 点，下跌 4.99%；原料药 报收 8034.05 点，下跌 6.38%；化学制剂报收 6269.94 点，下跌 3.39%；中药Ⅲ 报收 5957.62 点，下跌 3.59%；血液制品报收 10505.52 点，下跌 4.14%；疫苗 报收 10927.55 点，下跌 6.32%；其他生物制品报收 7373.87 点，下跌 5.58%； 医疗设备报收 8887.54 点，下跌 4.36%；医疗耗材报收 4540.51 点，下跌 5.68%； 体外诊断报收 6877.71 点，下跌 6.5%；医 ...

证券研究报告 2024 年 8 月 27 日 湘财证券研究所 行业研究 电子行业点评报告 世界机器人大会召开闭幕，人形机器人汽车工业应 用取得进展 | --- | --- | --- | --- | --- | |------------------------|--------------------------------|----------------------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 相关研究： | | | | 核心要点： | | 1.《Q1 | 先进封装收入 | 102亿美 | | 世界机器人大会召开，多家厂商参展 | | 元，HPC | 和生成式AI | 需求将驱动 | | 8 月 21 日-25 日，世界机器 ...